Biogen Pharmachem Industries has informed about outcome of the Board Meeting of the Company held on Tuesday 18th May 2021 in accordance with SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, has been approved by the Board of Directors of the Company and taken on record the following items: Consideration and Approval of Audited Financial Result for the Year ended 31st March, 2021; Independent Audit Report in pursuance with Regulation 33 of SEBI (LODR) Regulat ions, 2015 for the FY 31st March, 2021. Further, the Company hereby declared that the Auditor of the Company has issued the Audit report under the Companies Act, 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended on March 31, 2021 with unmodified opinion.
The above information is a part of company’s filings submitted to BSE.
